CQ-16
CQ-16 is an orally active small molecule drug conjugate (SMDC) targeting prostate-specific membrane antigen (PSMA). CQ-16 exhibits highly selective antiproliferative activity between PSMA-positive and PSMA-negative prostate cells. In addition, CQ-16 also has PARP inhibitory activity (IC50=1 nM). (Pink: PSMA Ligand ; Black: Linker (HY-W037980) ; Blue: PARP Inhibitor (HY-10162) )
Product Specifications
CAS Number
3024354-59-1
UNSPSC
12352005
Target
PARP; PSMA
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Epigenetics; Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cq-16.html
Smiles
O=C1NN=C(C2=CC=CC=C21)CC3=CC=C(C(C(N4CCN(CC4)C(C5(NC(CCC(NCCCC[C@H](NC(N[C@H](C(O)=O)CCC(O)=O)=O)C(O)=O)=O)=O)CC5)=O)=O)=C3)F
Molecular Formula
C40H47FN8O12
Molecular Weight
850.85
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CysLT1 (CYSLTR1) (Center) Rabbit Polyclonal Antibody
